ClearPoint Neuro (CLPT) Change in Intangibles (2022 - 2023)
ClearPoint Neuro recorded quarterly Change in Intangibles of $167000.0 in Q4 2023, little changed quarter-over-quarter from $167000.0 in Q2 2023, and down 22.33% year-over-year from $215000.0 in Q4 2022.
ClearPoint Neuro's Change in Intangibles history runs 2 years deep, the most recent figure standing at $167000.0 for Q4 2023.
- In Q4 2023, Change in Intangibles fell 22.33% year-over-year to $167000.0; the TTM figure through Dec 2024 stood at $167000.0 (down 50.0% YoY), while the FY2023 annual figure was $334000.0, down 62.6% from the prior year.
- Change in Intangibles came in at $167000.0 for Q4 2023 at ClearPoint Neuro, roughly flat from $167000.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $562000.0 in Q3 2022 to a low of $116000.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -31.61 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 167,000.00 |
| Dec 31, 2023 | 167,000.00 |
| Jun 30, 2023 | 167,000.00 |
| Jun 30, 2023 | 167,000.00 |
| Dec 31, 2022 | 215,000.00 |
| Dec 31, 2022 | 215,000.00 |
| Sep 30, 2022 | 562,000.00 |
| Sep 30, 2022 | 562,000.00 |
| Mar 31, 2022 | 116,000.00 |
| Mar 31, 2022 | 116,000.00 |